Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Mittal

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Speech, Language, and Hearing Research : JSLHR|June 2, 2001
Swallowing and tongue function following treatment for oral and oropharyngeal cancerC L Lazarus, J A Logemann, B R Pauloski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancerJ L Oh, E E Vokes, M S Kies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primaryA Argiris, S M Smith, K Stenson, et al.
American Journal of Clinical Oncology|June 1, 1996
Management of early-stage Hodgkin's lymphoma. The radiation oncology experience at Northwestern University/Northwestern Memorial HospitalM A LaCombe, B B Mittal, L A Colangelo, et al.
Head & Neck|June 22, 2000
Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9M W Lingen, K W Chang, S J McMurray, et al.
Cancer|February 1, 1997
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer CenterI Athanasiadis, S Taylor, E E Vokes, et al.
Cancer|December 15, 1992
Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude miceB B Mittal, A M Zimmer, V Sathiaseelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancerS G Taylor, A K Murthy, D D Caldarelli, et al.
Cancer|November 1, 1996
Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinomaB B Mittal, M A Zimmer, V Sathiaseelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancerM S Kies, D J Haraf, F Rosen, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Speech, Language, and Hearing Research : JSLHR|June 2, 2001
Swallowing and tongue function following treatment for oral and oropharyngeal cancerC L Lazarus, J A Logemann, B R Pauloski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancerJ L Oh, E E Vokes, M S Kies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primaryA Argiris, S M Smith, K Stenson, et al.
American Journal of Clinical Oncology|June 1, 1996
Management of early-stage Hodgkin's lymphoma. The radiation oncology experience at Northwestern University/Northwestern Memorial HospitalM A LaCombe, B B Mittal, L A Colangelo, et al.
Head & Neck|June 22, 2000
Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9M W Lingen, K W Chang, S J McMurray, et al.
Cancer|February 1, 1997
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer CenterI Athanasiadis, S Taylor, E E Vokes, et al.
Cancer|December 15, 1992
Effects of hyperthermia and iodine-131-labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude miceB B Mittal, A M Zimmer, V Sathiaseelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancerS G Taylor, A K Murthy, D D Caldarelli, et al.
Cancer|November 1, 1996
Phase I/II trial of combined 131I anti-CEA monoclonal antibody and hyperthermia in patients with advanced colorectal adenocarcinomaB B Mittal, M A Zimmer, V Sathiaseelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancerM S Kies, D J Haraf, F Rosen, et al.
Pageof 5